2 unknown, 1 completed, 1 terminated. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 2, Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Feasibility: new trials by email Literature Review of Feasibility trials Research Report on Feasibility
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids. Autologous adipose derived stem cells - Keloid, Autologus Adipose Derived Stem Cells | Phase 2 | Completed | Makerere University | 8 | 2021-03-01 | 2021-06-18 |
| TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms MDG1011, Investigator Choice therapy - Safety, Tolerability | Phase 1 / Phase 2 | Terminated | Medigene AG | 9 | 2018-03-27 | 2023-02-15 |
| Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma Poor responder group adjuvant chemotherapy, Good responder group adjuvant chemotherapy - Osteosarcoma, Feasibility | Phase 2 | Unknown | Byung-Kiu Park | 23 | 2018-02-01 | 2018-01-09 |
| Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma Photodynamic therapy - Treatment Response, Adverse Events | Phase 2 | Unknown | Asan Medical Center | 32 | 2016-01-01 | 2016-04-14 |
Keloid (1) · Osteosarcoma (1)
Cicatrix (1) · Collagen Diseases (1) · Connective Tissue Diseases (1) · Fibrosis (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Bone Tissue (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Sarcoma (1) · Skin and Connective Tissue Diseases (1)
Asan Medical Center (1) · Byung-Kiu Park (1) · Makerere University (1) · Medigene AG (1)
South Korea (2) · Germany (1) · Uganda (1)
Byung-Kiu Park, M.D., Ph.D. (1) · Do Hyun Park, Md, PhD (1) · Simone Thomas, PD Dr. med. (1)